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Abstract
BACKGROUND: Acne vulgaris (AV) is a health problem that is routinely found throughout the world and has 
an impact on the quality of life of sufferers. Several studies have shown that forkhead box Class O1 (FoxO1), 
the mammalian target of rapamycin complex 1 (mTORC1), survivin, and interleukin-17 (IL-17) play a role in the 
pathogenesis of multifactorial AV.
AIM: The study aims to determine the relationship between serum levels of FoxO1, mTORC1, survivin, and IL-17 
with the severity of AV.
METHODS: This is observational research with cross-sectional design. Samples from venous blood sufferers of 
AV mild, moderate, and severe, each of 20 people were colected. Classification of AV was based on the criteria of 
Lehmann et al. Examination of serum levels of FoxO1, mTORC1, survivin, and IL-17 using the ELISA technique 
was done. The statistical test used was the ANOVA test and the Kruskal–Wallis test.
RESULTS: The results showed that average levels of FoxO1 decreased with increasing degree of severity of AV. 
An average increase in mTORC1, survivin, IL-17 levels with an increase in the severity of AV was found. Statistical 
test results showed a significant correlation of FoxO1, mTORC1, survivin levels, and the severity of AV (p < 0.05). 
IL-17 levels were not related to the severity of AV (p > 0.05).
CONCLUSION: This study concluded that FoxO1 levels decrease at increasing severity. Conversely, levels of 
mTORC1, survivin, and IL-17 increase with increasing degrees of the severity of AV.
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Introduction
Acne vulgaris (AV) is a chronic inflammatory 
disease in folliculopilosebaceous units. AV is a 
skin disorder found in many parts of the world [1,2]. 
In general, AV sufferers are teenagers who enter 
puberty and AV has psychological and social effects 
for sufferers. There are four factors that influence 
the process of AV, namely, forkhead box Class O1 
(FoxO1), mammalian target of rapamycin complex 1 
(mTORC1), survivin, and interleukin-17 (IL-17). AV 
usually appears with increasing androgen hormones in 
the body. Androgen activity is triggered by insulin-like 
growth factor-1 (IGF-1) [3].
IGF-1 can suppress FoxO1 nuclei in 
SZ95 sebocytes which play a role in increasing 
lipogenesis [4]. FoxO1 functions as a regulator in the 
pathogenesis of AV where FoxO1 integrates external 
and internal growth factors signals at the level of gene 
regulation [5]. Decreased activity of FoxO1 in sebocytes 
of AV patients and increased activity of mTORC1 and 
survivin was published [6]. mTORC1 is a regulator of 
cellular growth and proliferation, lipid synthesis, and 
protein translation [7]. Survivin is an apoptotic inhibitor 
protein and regulates cell division, cell proliferation, 
and survival. IL-17 is a pro-inflammatory cytokine that 
can cause tissue damage and degeneration during 
chronic inflammation [8]. The role of Th17 cells in the 
pathogenesis of AV is still new and interesting, further 
research is needed regarding the interaction of IL-17 
with the development of AV inflammation.
The key to the success of AV treatment is rational 
drug use based on type and degree of severity so that 
an increased understanding of the pathophysiology of 
AV will result in future anti-AV therapy ingredients and 
regimens. Until now, no research has been found on the 
relationship between levels of FoxO1, mTORC1, survivin, 
and IL-17 with clinical AV severity, especially in Jambi, 
Indonesia. Therefore, we have conducted research on the 
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relationship of levels of FoxO1, mTORC1, survivin, and 
IL-17 with the severity of AV. The study aims to determine 
the relationship between serum levels of FoxO1, 
mTORC1, survivin, and IL-17 with the severity of AV.
Materials and Methods
The study was conducted at the 
Dermatovenereology Polyclinic of Raden Mattaher 
Regional General Hospital, Jambi, Indonesia.
Sample size
The study population was all AV sufferers who 
came to the Dermatovenereology Polyclinic of Raden 
Mattaher Regional General Hospital, Jambi, Indonesia. 
The sample selection was based on inclusion and 
exclusion criteria with a total sample of AV patients 60 
people, consisting of 20 mild AV people, 20 moderate 
AV people, and 20 severe AV people.
Blood samples
Median cubital vein blood sampling was taken 
from 08.00 am to 11.00 am. Four milliliters venous blood 
samples were taken from each AV sufferer. Samples 
taken were included in two Vacutainer tubes. The first 
Vacutainer tube for survivin and IL-17 examination, 
left at room temperature for 30 min, centrifuged, and 
separated the insert serum into two cup samples. The 
second Vacutainer tube for an examination of FoxO1 
and mTORC1, left at room temperature for 2 h until the 
blood is frozen, centrifuged, and separated the insertion 
serum into two cup samples and stored at −20°C.
Instruments
The kit used for examining levels of FoxO1, 
mTORC1, survivin, and IL-17 is a Human FoxO1 ELISA 
kit from Elabscience (catalog no: E-EL-H1099), Human 
RPTOR ELISA kit from FineTest (catalog no: EH1810), 
Human survivin ELISA kit from Elabscience (catalog 
no: E-EL-H1584), and Human IL-17 Immunoassay 
Quantikine ELISA kit (catalog no: D1700, S1700, 
PD1700). The inspection procedure is carried out 
according to the instructions of the kit used.
Ethical approval
Before conducting the research, an ethical 
agreement was requested from the Research Ethics 
Committee of the Medical Faculty of Andalas University, 
Padang, Indonesia. This study was carried out ethical 
review tests at the Medical Faculty of Andalas University 
in Padang, Indonesia, and passed the Ethics Study on 
February 5, 2018 (No: 084/KEP/FK/2018).
Data analysis
Statistical analysis using SPSS software and 
normality tests using the Kolmogorov–Smirnov and 
Shapiro–Wilk tests. The results of data that are normally 
distributed, FoxO1, mTORC1, and survivin were 
analyzed by ANOVA parametric test. Data that are not 
normally distributed, namely, IL-17, are non-parametric 
tests using the Kruskal–Wallis test. Furthermore, the 
Bonferroni post hoc test was conducted to find out the 
groups that were significantly different and the level of 
significance received if p < 0.05.
Results  and Discussion
Relationship between FoxO1 levels and 
severity of AV
Based on the results of the study in Table 1, it 
was found that the average level of FoxO1 decreased 
with an increase in the severity of AV. The lowest 
FoxO1 levels are found in the most severe AV degrees 
(Figure 1).
Table 1: Relationship between FoxO1 levels and severity of 
acne vulgaris
Severity degree n FoxO1 p value
Average ± SD (ng/ml)
Mild 20 11.99 ± 12.37 0.006
Moderate 20 5.64 ± 3.87
Severe 20 4.21 ± 3.87
FoxO1: Forkhead box Class O1.
 This is because the reduced FoxO1 causes 
the genes and nuclear receptors involved in the AV to 
be activated resulting in increased signal transduction 
mediated by androgen receptors (ARs), increased 
cell proliferation, induction of lipase sebaceous, and 
upregulation of inflammatory cytokines [5].
0
5
10
15
20
Mild Moderate Severe
Figure 1: Relationship between forkhead box Class O1 levels and 
severity of acne vulgaris
FoxO1 not only suppresses protein synthesis 
and cell growth but also lipid metabolism. FoxO1 
regulates transcription factors for sterol response 
promoter element-binding protein 1 (SREBP1) lipid 
synthesis, suppresses the activity of peroxisome 
proliferator-activated receptor γ (PPARγ) and liver 
X receptor α (LXRα), both of which help stimulate 
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sebaceous gland lipogenesis and stimulate expression 
of p21 and p27 [9].
Growth factor stimuli and other stimuli activate 
the PI3K/Akt pathway, resulting in phosphorylation of 
the FoxO1 protein. Increased growth factors during 
puberty and a signal of growth factors that persist due 
to lifestyle stimulate FoxO1 release from the nucleus 
into the cytoplasm through the activation of the PI3K/
Akt pathway. Signals mediated by growth factor 
receptors are integrated at the PI3K/Akt activation 
level which ultimately results in core FoxO1 deficiency. 
The active kinase act translocates into the nucleus 
and phosphorylates the nucleus FoxO1, which is 
released from the nucleus into the cytosol, where 
FoxO1 is broken down by 14-3-3 cytoplasmic proteins, 
in ubiquitinylation and then destroyed in proteasomes 
(proteasomal degradation) [5].
Decreased core O1 fork box class has 
an effect on AR activity, PPARγ, LXRα, and gene 
expression that controls the cell cycle (cyclin 
D1, D2, p21, and p27), matrix modulation matrix 
metalloproteinase, activity of the SREBP1c, 
regulation of insulin glucose transporter protein-4 
sensitivity, innate and adaptive immune responses 
that regulate antimicrobial peptide synthesis, toll-like 
receptor-2 expression, and T-cell proliferation (total 
leukocytes count proliferation) [5,6].
FoxO1 links genetic, metabolic, and 
environmental factors in AV [7]. The concept of the 
core FoxO1 deficiency hypothesis in AV and the 
relationship of AV variants was first explained in AV that 
is exacerbated by the consumption of insulinotropic 
dairy products, carbohydrates that have a high 
glycemic index, smoking effects that stimulate AV, 
psychological stress, aneugenic effect of polyaromatic 
hydrocarbons, fibroblast growth effects mutant factor 
receptor-2 in Apert syndrome and nevus akneiformis, 
and AV-induced IL-1α in pyogenic arthritis, pyoderma 
gangrenosum, and acne syndrome [5].
The results of this study are in accordance 
with the research of Agamia et al. who used blood 
samples and tissue biopsy from lesions of patients 
with AV and normal skin in healthy controls found 
significant differences in the expression of FoxO1 and 
mTORC1 immunohistochemically between groups 
of AV patients and healthy controls. FoxO1 core 
expression in the healthy control group was higher 
than in the group of AV sufferers. Patients with high 
glycemic load consumption diets and sufferers with 
severe AV are significantly associated with lower 
FoxO1 core expression [7].
The results of this study prove the decline of 
FoxO1 in increasing AV degrees and provide insight 
into therapeutic strategies in the treatment of AV by 
increasing FoxO1 levels. AV trigger factors use the 
action by reducing FoxO1 levels. Retinoids, antibiotics, 
and dietary interventions will increase FoxO1 further 
normalize the increase in transcription of genes involved 
in AV [10].
Relationship of mTORC1 levels with 
severity of AV
Based on the results of the study in Table 2, it 
was found that the average mTORC1 level increased with 
an increase in the severity of AV (Figure 2). Increased 
mTORC1 levels will increase the severity of AV. This is 
because the increased activation of mTORC1 is able 
to activate lipogenesis and increase cell growth and 
proliferation. Mammalian target of rapamycin complex 
1 positively regulates the activity of SREBP1, the main 
transcription factor of lipid biosynthesis. Mammalian 
target of rapamycin complex 1 regulates SREBP1 by 
controlling lipin 1, a phosphatidic acid phosphatase [9].
Table 2: Relationship of mTORC1 levels with severity of acne 
vulgaris
Severity degree n mTORC1 p value
Average  ±  SD (ng/ml)
Mild 20 0.06  ±  0.02 0.002
Moderate 20 0.09  ±  0.04
Severe 20 0.55  ±  0.80
mTORC1: Mammalian target of rapamycin complex 1.
There are two mTORC1 activation pathways, 
namely, activation of Rheb GTPase through growth 
factor signals and high cellular energy levels, and 
translational inactive mTORC1 to active Rheb located 
in the endosome or lysosome compartment. Rheb 
activity is regulated by TSC1 and TSC2 proteins that 
form a functional heterodimer complex [10].
-0.20
0.00
0.20
0.40
0.60
0.80
Mild Moderate Severe
Figure 2: Relationship of mammalian target of rapamycin complex 1 
levels with severity of acne vulgaris
mTORC1 is able to integrate various intra- and 
extra-cellular mediators such as growth factors (insulin, 
IGF-1) and energy signals (glucose, AMP/ATP ratio), 
control the adequate availability of amino acids, 
especially leucine, which is needed for its activation [6]. 
Insulin, IGF-1, long-chain amino acids, glutamine, and 
palmitate activate mTORC1. After the peak of puberty, 
the serum levels of IGF-1, the main growth hormone 
of puberty, decrease continuously. During puberty, 
mTORC1-mediated activation of nutrients overlaps with 
mTORC1 activation due to puberty (androgen/IGF-1), 
which triggers an AV epidemic [11].
Excessive activation of mTORC1 increases 
the secretion of androgen hormones and increases 
mTORC1 signaling from sebaceous follicles [12]. 
The results of this study are consistent with research 
by Agamia et al. who found significant differences in 
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FoxO1 and mTORC1 expression between groups of 
AV sufferers and healthy controls. mTORC1 is more 
expressed in the cytoplasm and nucleus in patients 
with high serum IGF-1. Patients with high glycemic 
load consumption and patients with severe AV were 
significantly associated with higher cytoplasmic 
mTORC1 expression [7]. However, it is different from 
Monfrecola et al. who found that mTORC1 increase 
was not related to AV severity [13].
Research by Monfrecola et al., on skin biopsy 
of AV lesions and non-lesions of AV patients and 
healthy controls, found that mTORC1 gene expression 
was significantly increased in AV patients in both 
lesions and non-lesions compared to healthy controls. 
However, the difference in increase in mTORC1 was 
not significant compared between AV lesions and non-
lesions in AV patients. Ribosomal protein phosphate-
S6K1 is increased in both lesions and non-lesions of 
AV patients compared to healthy controls. Phospho-S6 
ribosomal protein is one of the downstream regulators 
that are activated by mTORC1 and controls SREBP1 
activity, which further increases AV lesions. Ribosomal 
protein Phospho-S6 increases in AV skin indirectly 
allowing the activation of mTORC1 and can increase 
lipogenesis [13].
The current research shows that increasing 
mTORC1 plays a role in the pathogenesis and 
increasing severity of AV so that the mTORC1 inhibitors 
are expected to be effective for the treatment of AV. 
In AV therapy, the pathway that stimulates mTORC1 
activation needs to be passed down, either through 
drugs or dietary interventions. The recommended 
dietary interventions are reducing the total energy 
of glucose and fat; limiting insulin/IGF-1 signals from 
protein consumption of dairy products; and limiting 
total leucine [10]. FoxO1 is a negative regulator of 
mTORC1 activity. Increased Akt/mTORC1 signal 
increases sebocyte survival, growth, and lipogenesis 
which will increase the growth of Propionibacterium 
acnes and the formation of biofilms, hyperseborrhea, 
and dysseborrhea by increasing the release of free fatty 
acids which will stimulate inflammation [6].
Relationship between survivin levels and 
the severity of AV
Based on the results of the study in Table 3, it 
was found that survivin levels increased with increasing 
severity of AV. Increased survivin levels also increase 
the severity of AV (Figure 3). This is because excessive 
survivin will inhibit apoptosis, both in keratinocyte cells 
and sebocyte cells resulting in cell hyperproliferation. 
Increased keratinocyte cell proliferation is needed for 
the growth and maintenance of AV lesions. Increased 
survivin also inhibits sebocyte apoptosis so that it 
will increase the total amount of sebum, which is an 
important energy source for P. acnes growth. Increased 
P. acnes growth will increase P. acnes triglyceride 
lipase and free palmitate formation from sebum. Free 
P. acnes and palmitate are important signals that 
activate inflammatory NLRP3 so that they release 
cytokines such as IL-1α, IL-1β, IL-6, IL-8, and tumor 
necrosis factor-α (TNF-α) that cause the development 
of inflammatory lesions [6].
Table 3: Relationship between survivin levels and the severity 
of acne vulgaris
Severity degree n Survivin p value
Average ± SD (pg/ml)
Mild 20 72.65 ± 33.61 0.016
Moderate 20 99.19 ± 38.22
Severe 20 124.64 ± 81.03
Survivin acts as a pro-survival of sebocytes and 
keratinocytes. Survivin is expressed in keratinocytes 
from the basal cell layers of the interfollicular epidermis 
and human sebocytes [14]. Survivin plays a role in 
homeostasis by inhibiting apoptosis and regulating cell 
division, proliferation, and cell survival [15]. Excessive 
expression of survivin inhibits apoptosis. Apoptosis is a 
counterweight to proliferation, and decreased apoptosis 
is associated with epidermal hyperproliferation. 
Increased keratinocyte proliferation is a consistent 
picture of AV lesions and is needed for growth and 
maintenance of AV lesions [16].
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Figure 3: Relationship between survivin levels and the severity of 
acne vulgaris
The results of this study are consistent with 
the research of Assaf et al. who examined serum IGF-1 
and survivin levels, and their expression in skin tissue 
in 15 patients with active lesions and 15 patients with 
post-inflammatory scar tissue compared with 15 healthy 
control individuals showed that serum survivin levels 
were significantly higher in active AV and AV scarring 
compared to healthy controls. Serum survivin levels 
were significantly higher in the AV scar group than in 
the active AV group. Increased survivin can affect the 
sebaceous glands and perifollicular dermal tissue in the 
formation of scar tissue. Survivin expression is related 
to the pathogenesis of fibrosis in fibrotic diseases 
including the process of AV scarring. However, this 
study did not compare survivin levels with the severity 
of AV [15]. Sebocytes undergoing apoptosis reduce the 
total amount of sebum which is an energy source for 
the growth of P. acnes so that the growth of P. acnes 
is reduced. Decreased P. acnes decreases the amount 
of triglyceride lipase and the formation of free palmitic 
acid so that it will reduce inflammation activation which 
is ultimately expected to reduce the severity of AV. The 
development of new drugs with low-molecular-weight 
survivin inhibitors is expected to lead to new treatment 
options for AV with survivin regulation strategies.
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Relationship between IL-17 levels and the 
severity of AV
Based on the results of the study in Table 4 
and Figure 4, it was found a tendency to increase the 
average level of IL-17 with an increase in the severity 
of AV. In AV, IL-17 secretion from Th17 cells is obtained 
through differentiation of CD4 T cells with the help of 
cytokines induced by P. acnes, namely, IL-1β, IL-6, and 
tumor growth factor-β (TGF-β) [17], where cytokines 
are cytokines this pro-inflammation results from early 
inflammatory lesions of AV [18].
Table 4: Relationship between IL-17 levels and the severity of 
acne vulgaris
Severity degree n IL-17 p value
Average ± SD (pg/ml)
Mild 20 6.45 ± 1.71 0.700
Moderate 20 6.78 ± 1.99
Severe 20 7.01 ± 3.36
IL-17: Interleukin-17.
Statistical test results showed no significant 
difference from the average IL-17 level based on the 
severity of AV (p > 0.05). These results indicate that 
inflammation has occurred in every degree of AV, even 
since the beginning of the AV process. Inflammation 
is one of the important factors that play a role in the 
pathogenesis of AV. Inflammation that occurs in AV 
is mainly induced by immunological reactions to 
P. acnes and these bacteria can increase the immune 
response in the sebaceous glands. P. acnes can trigger 
inflammatory responses and induce monocytes to 
secrete pro-inflammatory cytokines that play a role in 
initiating the formation of inflammatory AV lesions, such 
as IL-17, IL-1β, IL-6, TGF-β, IL-1α, IL-8, and TNF-α [17].
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Figure 4: Relationship between interleukin-17 levels and the severity 
of acne vulgaris
The inflammatory process is often referred to 
as a secondary process that occurs in AV. Inflammatory 
lesions in the form of papules, pustules originate from 
lesions that are clinically referred to as non-inflammatory 
lesions, namely, comedones. Blackheads are clinically 
non-inflammatory lesions but, in fact, blackhead lesions 
have occurred microscopic inflammation, as evidenced 
by the discovery of IL-1α pro-inflammatory cytokines in 
comedones lesions [19].
In the development of AV lesions, follicular 
rupture occurs resulting in the release of P. acnes, 
sebum, and cellular debris into the dermis which 
increases inflammation. P. acnes or secreted cytokines 
can interact with immune cells in the dermis also affect 
the development of Th17. P. acnes can also initiate 
specific immune responses through the recruitment of 
T-cell populations, depending on the type of lesions and 
cytokines in their environment, the type of P. acnes, and 
the immune status of individuals [20].
In determining the severity of AV according 
to Lehmann criteria based on the calculation of the 
number of non-inflammatory lesions and the number 
of inflammatory lesions and total lesions so that in 
each group, mild, moderate, and severe AV degrees 
can contain both inflammatory and non-inflammatory 
lesions. In patients with AV, P. acnes was significantly 
increased compared to non-AVs. P. acnes can be 
found in inflammatory and non-inflammatory lesions. 
The number of P. acnes bacteria found is more in 
inflammatory lesions when compared with non-
inflammatory lesions and an inflammatory lesion 
can provide a more suitable environment and more 
nutrients for P. acnes colonization so as to enhance 
the inflammatory process [21]. Clinically, blackheads 
are non-inflammatory lesions, but microscopically 
are inflammatory lesions as evidenced by IL-1α 
pro-inflammatory cytokines found in comedones 
lesions [22]. In blackheads, lesions can be found other 
cytokines such as TNF-α and CD + T-cells in large 
numbers [23]. Inflammatory cells (CD3 and CD4 T-cells) 
are also found to be increased in microcutaneous 
lesions with a number that is not much different when 
compared with pustular lesions [24].
These results are consistent with the study of 
Maulinda (2016) who used blood samples of patients 
with AV comedonal lesions and papulopustular showed 
that serum IL-17 levels of papulopustular type AV 
patients were no different compared with comedonal 
type AVs. Research by Kistowska et al., using biopsies 
and blood samples of moderate AV patients, showed 
that Th17 and Th17/Th1 cells induced by P. acnes can 
be found in peripheral blood cells of AV patients and in 
low concentrations in healthy individuals [25]. However, 
the research of Kistowska et al. did not compare with 
the degree of severe AV and mild AV. Pathogenesis of 
AV associated with various systemic and environmental 
risk factors shows that AV is not a simple disease. AV 
is influenced by various intrinsic, extrinsic, and genetic 
backgrounds. The possibility of polymorphism as a 
genetic factor was not investigated [25].
Conclusion
This study concluded that FoxO1 levels 
decrease at increasing severity. Conversely, levels of 
mTORC1, survivin, and IL-17 increase with increasing 
degrees of severity of AV.
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